基金经理：刘杰
| 单位净值:1.4229 | 净值增长率:0.27% | 累计净值:1.4229 | 截止日期:2026/1/12 | ||
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:8.77亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
广发中证香港创新药ETF发起式联接(QDII)A(019670)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2025/9/30 | 205,640,000 | 616,064,000 | 825,943,000 | 415,520,000 | 410,423,000 | 199.58% |
| 2025/6/30 | 56,632,300 | 205,640,000 | 285,498,000 | 136,489,000 | 149,009,000 | 263.12% |
| 2025/6/30 | 122,306,000 | 205,640,000 | 197,898,000 | 114,563,000 | 83,335,000 | 68.14% |
| 2025/3/31 | 56,632,300 | 122,306,000 | 87,599,800 | 21,926,500 | 65,673,300 | 115.96% |
| 2024/12/31 | 16,770,500 | 56,632,300 | 68,715,900 | 28,854,100 | 39,861,800 | 237.69% |
| 2024/12/31 | 48,012,900 | 56,632,300 | 24,514,100 | 15,894,600 | 8,619,500 | 17.95% |
| 2024/9/30 | 33,229,200 | 48,012,900 | 21,306,000 | 6,522,370 | 14,783,630 | 44.49% |
| 2024/6/30 | 16,770,500 | 33,229,200 | 22,895,800 | 6,437,100 | 16,458,700 | 98.14% |
| 2024/6/30 | 23,695,200 | 33,229,200 | 12,853,900 | 3,319,940 | 9,533,960 | 40.24% |
| 2024/3/31 | 16,770,500 | 23,695,200 | 10,041,900 | 3,117,160 | 6,924,740 | 41.29% |
| 2023/12/31 | 10,325,300 | 16,770,500 | 7,071,240 | 626,106 | 6,445,134 | 62.42% |
| 2023/12/31 | 10,325,300 | 16,770,500 | 7,071,240 | 626,106 | 6,445,134 | 62.42% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。